Successful vaccination for Lyme disease:a novel mechanism

JOURNAL ARTICLE published January 1999 in Expert Opinion on Investigational Drugs

Authors: Wendy T Thanassi | Robert T Schoen

D-Sotalol: death by the SWORD or deserving of further consideration for clinical use?

JOURNAL ARTICLE published July 2000 in Expert Opinion on Investigational Drugs

Authors: Sheila A Doggrell | Lindsay Brown

Recent developments in the therapy of acromegaly

JOURNAL ARTICLE published March 2006 in Expert Opinion on Investigational Drugs

Authors: Angela N Paisley | Peter J Trainer

Management of metastatic HER2-positive breast cancer progression after adjuvant trastuzumab therapy – current evidence and future trends

JOURNAL ARTICLE published April 2010 in Expert Opinion on Investigational Drugs

Authors: Otto Metzger-Filho | Tushar Vora | Ahmad Awada

Ospemifene use in postmenopausal women

JOURNAL ARTICLE published June 2009 in Expert Opinion on Investigational Drugs

Authors: Luigi Gennari | Daniela Merlotti | Fabrizio Valleggi | Ranuccio Nuti

Phase II drugs under investigation for allergic conjunctivitis

JOURNAL ARTICLE published December 2014 in Expert Opinion on Investigational Drugs

Authors: Monica Baiula | Santi Spampinato

Current and emerging investigational venetoclax-based therapies in chronic lymphocytic leukemia

JOURNAL ARTICLE published 3 June 2021 in Expert Opinion on Investigational Drugs

Authors: Stefano Molica | David Allsup | Valentina Gianfelici | Luciano Levato | Vincenzo Aiello | James Bailey | Aaron Polliack

Insulin aspart: a novel rapid-acting human insulin analogue

JOURNAL ARTICLE published September 1999 in Expert Opinion on Investigational Drugs

Authors: Steen Gammeltoft | Bo Falck Hansen | Lars Dideriksen | Anders Lindholm | Lauge Schäffer | Thomas Trüb | Anthony Dayan | Peter Kurtzhals

Investigational cannabinoids in seizure disorders, what have we learned thus far?

JOURNAL ARTICLE published 3 June 2018 in Expert Opinion on Investigational Drugs

Authors: Dejana Ružić Zečević | Marko Folić | Ziyad Tantoush | Milan Radovanović | Goran Babić | Slobodan M. Janković

Developing drug therapies in bronchiectasis

JOURNAL ARTICLE published February 2015 in Expert Opinion on Investigational Drugs

Authors: Manjit K Sidhu | Pallavi Mandal | Adam T Hill

Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?

JOURNAL ARTICLE published June 2011 in Expert Opinion on Investigational Drugs

Authors: Luca Antonioli | Matteo Fornai | Rocchina Colucci | Marco Tuccori | Corrado Blandizzi

Gut peptides in the treatment of diabetes mellitus

JOURNAL ARTICLE published March 2004 in Expert Opinion on Investigational Drugs

Authors: Torsten P Vahl | David A D’Alessio

Novel pharmacological treatments for heart failure

JOURNAL ARTICLE published November 2003 in Expert Opinion on Investigational Drugs

Authors: WH Wilson Tang | Gary S Francis

Potential new drug treatments for congestive heart failure

JOURNAL ARTICLE published 2 July 2016 in Expert Opinion on Investigational Drugs

Authors: Hao A. Tran | Felice Lin | Barry H. Greenberg

Oncolytic viruses as novel anticancer agents: turning one scourge against another

JOURNAL ARTICLE published February 2000 in Expert Opinion on Investigational Drugs

Authors: E Antonio Chiocca | Edward R Smith

JOURNAL ISSUE published April 2001 in Expert Opinion on Investigational Drugs

Heparin as an anticancer therapeutic

JOURNAL ARTICLE published July 2008 in Expert Opinion on Investigational Drugs

Authors: Leo R Zacharski | Agnes YY Lee

Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia

JOURNAL ARTICLE published November 2006 in Expert Opinion on Investigational Drugs

Authors: John R Burnett | Murray W Huff

Colon cancer angiogenesis and antiangiogenic therapy

JOURNAL ARTICLE published June 2004 in Expert Opinion on Investigational Drugs

Authors: Curtis J Wray | Horatio L Rilo | Syed A Ahmad

Metal-protein attenuating compounds and Alzheimer’s disease

JOURNAL ARTICLE published December 2004 in Expert Opinion on Investigational Drugs

Authors: Craig W Ritchie | Ashley I Bush | Colin L Masters